Tobias Ruf

Tobias Ruf

Interventional cardiologist / Cardiologist
Universitätsmedizin der Johannes Gutenberg-Universität Mainz - Mainz, Germany

Latest contributions

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

22 May 2025 – From EuroPCR 2025

An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

The right ventricle - Key determinant of tricuspid procedural planning and clinical outcomes

26 Nov 2024 – From PCR London Valves 2024

Looking to know more about the role of the right ventricle in the pathophysiology of tricuspid regurgitation? Don’t miss this video!

You’ll learn how to assess RV function and morphology with advanced imaging, uncover key parameters that predict outcomes, understand how RV remodeling impacts procedural success, and...

The right ventricle - Key determinant of tricuspid procedural planning and clinical outcomes

Transcatheter tricuspid valve replacement - The fundamentals

26 Nov 2024 – From PCR London Valves 2024

Interested in learning the key steps for successful transcatheter tricuspid valve replacement?

Join this session to refine your skills in patient selection, procedural planning and execution. You'll explore a real-world case of a 62-year-old patient with heart failure symptoms and gain insights from the TRISCEND II study.

Transcatheter tricuspid valve replacement - The fundamentals

TEER for primary mitral regurgitation - LIVE case

15 May 2024 – From EuroPCR 2024

A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...

Mitral TEER

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

PCR Tricuspid Focus Group - referral meeting in Mainz

10 Jul 2023

Join your peers for this meeting on 7 September 2024 in Mainz, Germany!